Breaking News

Olon to Build New R&D Center in Italy

The CDMO is investing €10 million to create a large area dedicated entirely to research laboratories to be used to develop API manufacturing processes.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Olon, an active pharmaceutical ingredient (API) supplier, is creating an R&D hub at its center in Milan, Italy, also home to the company’s headquarters. The company plans to expand and diversify its expertise applied to the development of APIs for the contract development and manufacturing organization (CDMO) and generics market. With a €10 million investment, the Italian Group has unveiled the creation of a large area dedicated entirely to research laboratories to be used to develop API ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters